Latest news
How Q2 Results and Alina GLP-1 Approvals At Stevanato Group (STVN) Have Changed Its Investment Story - simplywall.stsimplywall.st · Sun, 09 Aug 2026 08:50:33 GMTLiraglutide combination products using Stevanato Group pen gain European approval - Drug Store NewsDrug Store News · Fri, 07 Aug 2026 12:30:51 GMTStevanato Group Q2 2026 Earnings Call: Complete Transcript - SahmSahm · Wed, 05 Aug 2026 19:29:25 GMTSTVN: Q2 2026 delivered robust revenue and margin growth, led by high-value biologics and GLP-1 solutions - TradingViewTradingView · Tue, 04 Aug 2026 14:50:29 GMTGLP-1 therapies delivered by Stevanato Group pen injectors get green light in Europe - Drug Delivery BusinessDrug Delivery Business · Thu, 30 Jul 2026 17:25:45 GMT